Last updated on December 2018

Cannabidiol - an in Vivo Innovative Drug Delivery Study

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Pharmacokinetics | Bioavailability
  • Age: Between 18 - 85 Years
  • Gender: Male or Female

Inclusion Criteria:

  • Informed consent given by the subject
  • Negative drug screening at the time of screening
  • Non-smoking
  • In female participants in fertile age, reliable contraception, which means contraception's Pearl index is equal to or smaller than 1.
  • Body Mass Index between 18.5 kg/m2 and 30 kg/m2

Exclusion Criteria:

  • Lack of accountability
  • Pregnancy or lactation phase in females at the time of screening
  • Any known psychiatric or neurological illness in the participant's history.
  • Known family history regarding psychiatric disorders with an increased lifetime risk for psychiatric disorders in the participant (investigators qualified judgement)
  • Relevant use of cannabis (which is defined on the present state of knowledge as more than five times lifetime consumption and/or more than two consumptions during the last year)
  • Consumption of any illicit drugs (except cannabis in history, see above)
  • Severe physical (internal) or neurological illness, especially cardiovascular, renal, advanced respiratory, haematologic or endocrinologic disorders or infectious diseases (acute hepatitis A, B or C or HIV) assessed at the time of the screening by the subject's history, clinical examination and laboratory testing, as assessed by the investigator

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.